FDA approved Pylarify TruVu, a higher-radioactivity-concentration formulation of piflufolastat F 18 designed to increase batch size and distribution efficiency while maintaining the established ...
About 60% of low‑risk prostate cancer patients are opting for active surveillance — and long‑term survival remains high.
Manufacturing optimization is projected to expand batch output by ~50%, improving supply reliability and supporting higher-throughput PSMA PET imaging services. Increased radioactivity extends shelf ...
Bob Lane emphasizes the importance of having a support system during prostate cancer diagnosis and treatment to help process information and provide emotional support. Lane's experience with cancer ...
Imagine being told you have prostate cancer and then learning that the treatment you are offered could leave you with life-changing side effects, even though you might not need it at all. That is the ...
A large language model (LLM)-based multi-agent framework for risk stratification and treatment recommendations in localized prostate cancer (locPCa). This is an ASCO Meeting Abstract from the 2025 ...
Incontinence and other urinary problems after prostate cancer treatment can be eased with Kegel exercises, bladder training, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results